republic-os/legislation/us/states/in/2024/sb-273.md

---
type: "Bill"
title: "Biomarker testing coverage."
description: "Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing."
jurisdiction: "us/states/in"
legislature: "Indiana General Assembly"
session: "2024"
identifier: "SB 273"
citation: "Indiana SB 273 (2024)"
classification: ["bill"]
subjects: ["AGENCIES; Family and Social Services Administration (FSSA)", "HEALTH; Generally", "HEALTH; Medicaid", "INSURANCE; Health Insurance", "STATE GOVERNMENT; Federal Funding"]
status: "enacted"
primary_sponsors: ["Brad Barrett", "Ed Charbonneau", "Jean Leising", "Vaneta Becker"]
version_count: 4
action_count: 31
vote_count: 2
first_action: "2024-01-11"
last_action: "2024-03-11"
source: "openstates"
source_identifier: "ocd-bill/8dae05ee-aee9-41e9-a1ba-bee1b3d14fec"
source_url: "https://api.iga.in.gov/2024/bills/sb0273"
source_hash: "d790cfc08f45d3f623486cdaca32ffdb01407ae4520a1e9d4879044b21ce365d"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-in"]
---

# Indiana SB 273 (2024) — Biomarker testing coverage.

Requires a health plan (which includes a policy of accident and sickness insurance, a health maintenance organization contract, the Medicaid risk based managed care program, and a state employee health plan) to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an enrollee's disease or condition when biomarker testing is supported by medical and scientific evidence. Requires the office of Medicaid policy and planning to provide biomarker testing as a Medicaid program service, and to apply to the United States Department of Health and Human Services for approval of any waiver necessary under the federal Medicaid program for the purpose of providing biomarker testing. Provides that coverage is not required for biomarker testing for screening purposes. Provides that if a prior authorization requirement applies to biomarker testing, the health plan or a third party acting on behalf of the health plan must: (1) approve or deny a request for prior authorization; and (2) notify the covered individual of the approval or denial; in not more than five business days in the case of a nonurgent request or in not more than 48 hours in the case of an urgent request. Requires the office of the secretary of family and social services to report certain information to the budget committee on Medicaid reimbursement rates provided for biomarker testing.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **Enrolled Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/123/2024/senate/bills/SB0273/SB0273.06.ENRH.pdf)
2. **Introduced Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/123/2024/senate/bills/SB0273/SB0273.01.INTR.pdf)
3. **Senate Bill (H)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/123/2024/senate/bills/SB0273/SB0273.04.COMH.pdf)
4. **Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/123/2024/senate/bills/SB0273/SB0273.05.COMH.pdf)

## Votes

- SB 273 - Barrett - 3rd Reading — **94–0** (pass) · lower
- SB 273 - Charbonneau - 3rd Reading — **47–1** (pass) · upper

## Sponsors

- Brad Barrett — primary (person)
- Ed Charbonneau — primary (person)
- Jean Leising — primary (person)
- Vaneta Becker — primary (person)
- Edward Clere — cosponsor (person)
- Eric Bassler — coauthor (person)
- Fady Qaddoura — coauthor (person)
- Gregory Porter — cosponsor (person)
- J.D. Ford — coauthor (person)
- Lonnie Randolph — coauthor (person)
- Matt Lehman — cosponsor (person)
- Mike Bohacek — coauthor (person)
- Shelli Yoder — coauthor (person)
- Susan Glick — coauthor (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2024-01-11** First reading: referred to Committee on Insurance and Financial Institutions `reading-1, referral-committee`
- **2024-01-11** Authored by Senators Charbonneau and Becker
- **2024-01-16** Senator Qaddoura added as coauthor
- **2024-01-18** Senator Leising added as third author
- **2024-01-18** Committee report: amend do pass adopted; reassigned to Committee on Appropriations `committee-passage, referral-committee`
- **2024-01-22** Senator Bohacek added as coauthor
- **2024-01-23** Senator Bassler added as coauthor
- **2024-01-25** Senator Glick added as coauthor
- **2024-02-01** Senator Ford J.D. added as coauthor
- **2024-02-01** Senator Randolph added as coauthor
- **2024-02-01** Senator Yoder added as coauthor
- **2024-02-01** Committee report: amend do pass, adopted `committee-passage`
- **2024-02-05** Second reading: ordered engrossed `reading-2`
- **2024-02-06** Third reading: passed; Roll Call 142: yeas 47, nays 1 `passage, reading-3, reading-3`
- **2024-02-06** House sponsor: Representative Barrett
- **2024-02-07** Referred to the House `referral`
- **2024-02-12** First reading: referred to Committee on Insurance `reading-1, referral-committee`
- **2024-02-13** Representative Clere added as cosponsor
- **2024-02-15** Representative Porter added as cosponsor
- **2024-02-15** Representative Lehman added as cosponsor
- **2024-02-15** Referred to the Committee on Ways and Means pursuant to House Rule 127
- **2024-02-15** Committee report: do pass, adopted `committee-passage`
- **2024-02-22** Committee report: do pass, adopted `committee-passage`
- **2024-02-26** Second reading: ordered engrossed `reading-2`
- **2024-02-27** Third reading: passed; Roll Call 236: yeas 94, nays 0 `passage, reading-3, reading-3`
- **2024-02-28** Returned to the Senate without amendments `receipt`
- **2024-03-04** Signed by the President Pro Tempore `passage`
- **2024-03-07** Signed by the Speaker `passage`
- **2024-03-08** Signed by the President of the Senate `passage`
- **2024-03-11** Signed by the Governor `executive-signature`
- **2024-03-11** Public Law 37 `became-law`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/8dae05ee-aee9-41e9-a1ba-bee1b3d14fec`. Confidence: reported (aggregated from official Indiana legislature records).